Feng Zhang PhD

Dr. Zhang joined the faculty of Neurology in November of 2009. His research interest focuses on experimental cerebral ischemia and neuroprotection using small molecular proteins, chemical compounds or ischemic preconditioning. His projects include the neuroprotective effects of synthetic triterpenoids, hypothermia, ischemic preconditioning, and omega-3 fatty acids, which are high in fish oil.

He is also interested in the mechanisms responsible for the protection of these approaches, including various signaling pathways and antioxidative enzymes. His recent researches focus on the Nrf2 pathway in neuroprotection mediated ischemic preconditioning, which is supported by an NIH R01 grant. Dr. Zhang serves as an editorial board member for the NS & Neurological Disorders‐Drug Targets and Austin Journal of Cerebrovascular Disease & Stroke, and an ad-hoc referee for a number of journals, including Neurobiology of Disease, CNS Neuroscience & Therapeutics, Brain Research, Translational Stroke Research, Plos One, Journal of Visualized Experiments, Molecular Neurobiology, Pharmacology, Neuroscience and Scientific Reports.